Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 7Cholangiocarcinoma 5Neoplasms 2Jaundice 2Biliary Tract Neoplasms 2Bile Duct Neoplasms 2Pancreatic Cancer Metastatic to Liver 1Klatskin Tumor 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Fistula 1Disease 1Cholestasis 1

Interventions

Gemcitabine 92Cisplatin 70Oxaliplatin 37Capecitabine 37durvalumab 29Fluorouracil 26pembrolizumab 24Leucovorin 22S 1 (combination) 18Nivolumab 13Irinotecan 13Bevacizumab 13lenvatinib 12tremelimumab 10apatinib 8Trastuzumab 7Injections 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7Paclitaxel 6Immune Checkpoint Inhibitors 6Docetaxel 6titanium silicide 5surufatinib 5envafolimab 5camrelizumab 5atezolizumab 5Folfox protocol 5Drug Therapy 5Carboplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Biliary Tract Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT03063554 2017-02-24

BILPAL

Weill Medical College of Cornell University

Phase NA Unknown
120 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT01758341 2014-01-23

Radiofrequency Ablation for Malignant Biliary Obstruction

Medical University of Vienna

Phase 4 Completed
58 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡